Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Oramed Pharmaceuticals (ORMP) Return on Capital Employed (2022 - 2025)

Oramed Pharmaceuticals (ORMP) has disclosed Return on Capital Employed for 3 consecutive years, with 0.08% as the latest value for Q3 2024.

  • For the quarter ending Q3 2024, Return on Capital Employed rose 13.0% year-over-year to 0.08%, compared with a TTM value of 0.08% through Sep 2024, up 13.0%, and an annual FY2023 reading of 0.11%, changed N/A over the prior year.
  • Return on Capital Employed was 0.08% for Q3 2024 at Oramed Pharmaceuticals, down from 0.07% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.07% in Q2 2024 and bottomed at 0.27% in Q4 2022.
  • Average Return on Capital Employed over 3 years is 0.15%, with a median of 0.14% recorded in 2023.
  • The sharpest move saw Return on Capital Employed rose 18bps in 2023, then increased 12bps in 2024.
  • Year by year, Return on Capital Employed stood at 0.27% in 2022, then soared by 67bps to 0.09% in 2023, then increased by 16bps to 0.08% in 2024.
  • Business Quant data shows Return on Capital Employed for ORMP at 0.08% in Q3 2024, 0.07% in Q2 2024, and 0.08% in Q1 2024.